Dr. Lucy Abgaryan: Finding Treatments for Myotonic Dystrophy

Dr. Lucy Abgaryan, the co-founder and CEO of GrittGene Therapeutics, a biotech company based in Los Angeles, California, joins us to discuss how her company is working to find treatments for Myotonic Dystrophy, a rare genetic disorder that causes progressive muscle loss and weakness. Lucy also shared with us her experience in trying to find opportunities to work with the local Armenian biotech industry. The post Dr. Lucy Abgaryan: Finding Treatments for Myotonic Dystrophy appeared first on EVN Report.